|
LMLN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.003190E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77059999999907E-05 |
| Normal-vs-Stage2 |
5.750400E-02 |
| Normal-vs-Stage3 |
4.781500E-02 |
| Normal-vs-Stage4 |
2.128200E-02 |
| Stage1-vs-Stage2 |
7.097000E-01 |
| Stage1-vs-Stage3 |
1.804580E-01 |
| Stage1-vs-Stage4 |
6.961200E-01 |
| Stage2-vs-Stage3 |
5.949200E-01 |
| Stage2-vs-Stage4 |
9.779000E-01 |
| Stage3-vs-Stage4 |
5.234800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.96329999999834E-05 |
| Normal-vs-AfricanAmerican |
7.436600E-01 |
| Normal-vs-Asian |
9.271600E-02 |
| Caucasian-vs-AfricanAmerican |
6.343400E-03 |
| Caucasian-vs-Asian |
4.243800E-01 |
| AfricanAmerican-vs-Asian |
4.057700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.019900E-03 |
| Normal-vs-Female |
3.79569999999774E-05 |
| Male-vs-Female |
1.522550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.472400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.55080000000729E-05 |
| Normal-vs-Age(61-80Yrs) |
3.916900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.366200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.370800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.300800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.196600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.776360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.455200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.567200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.88044999999137E-05 |
| Normal-vs-Grade 2 |
1.356310E-04 |
| Normal-vs-Grade 3 |
3.228700E-04 |
| Normal-vs-Grade 4 |
5.544400E-01 |
| Grade 1-vs-Grade 2 |
1.192220E-01 |
| Grade 1-vs-Grade 3 |
9.869800E-02 |
| Grade 1-vs-Grade 4 |
6.777500E-03 |
| Grade 2-vs-Grade 3 |
8.579000E-01 |
| Grade 2-vs-Grade 4 |
2.654300E-02 |
| Grade 3-vs-Grade 4 |
3.582300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.37409999992444E-07 |
| Normal-vs-ccB subtype |
3.445800E-02 |
| ccA subtype-vs-ccB subtype |
9.079900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.244600E-04 |
| Normal-vs-N1 |
2.087800E-01 |
| N0-vs-N1 |
9.064000E-01 |
|
|
